Market Overview

Mylan Adjusts Pricing Terms Of Manufacturing Pacts With Abbot

Related MYL
The Difference Between Mylan's EpiPen And Generic Offerings
The Market In 5 Minutes: Jobless Claims Lower, Trump Conference Shakes Sectors
Biotech Forum Daily Digest: Sector Gets 'Trumped' Again - Spotlight On Sucampo Pharmaceuticals (Seeking Alpha)


  • Mylan To Own 78% Of New Mylan Shares, Abbot To Own 22%
  • Mylan Amendment To Boost New Share Issuance To Total Of 110M
  • Mylan Still Sees Deal Closing In Q1 2015

Posted-In: News


Related Articles (MYL)

View Comments and Join the Discussion!